Pasqal director acquires 22.2M shares, warrants
Pasqal Holding SA (PSQL) reported that director and ten percent owner Georges-Olivier Reymond acquired equity interests in connection with the closing of a business combination involving Bleichroeder Acquisition Corp. II and Pasqal Holding SAS.
Rhea-AI Filing Summary
Pasqal Holding SA (PSQL) reported that director and ten percent owner Georges-Olivier Reymond acquired equity interests in connection with the closing of a business combination involving Bleichroeder Acquisition Corp. II and Pasqal Holding SAS. On August 27, 2026, he received 22,185,680 ordinary shares, reflecting an automatic conversion of ordinary shares of Legacy Pasqal into newly issued ordinary shares of Pasqal Holding SA based on an exchange ratio of 22.7361449900136.
On the same date, he was granted 8,000 Founder Share Subscription Warrants ("BSPCEs"), representing rights to acquire 181,889 ordinary shares, with an exercise price of EUR 50 per share and an expiration date of July 29, 2046. As of the filing date, 2,000 BSPCEs have vested and are exercisable for 45,472 ordinary shares, and the remaining BSPCEs vest in three equal annual installments starting March 15, 2027. No Rule 10b5-1 trading plan is reported for these transactions.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Founder Share Subscription Warrants ("BSPCEs") F1, F2, F4, F6, F5 | 8,000 | -- | -- |
| Grant/Award | Ordinary Shares F1, F2, F3 | 22,185,680 | -- | -- |
Footnotes (6)
- F1. Received pursuant to the consummation of the Issuer's business combination, in connection with the Agreement and Plan of Merger, dated as of February 28, 2026 (as amended, supplemented or otherwise modified from time to time, the "Business Combination Agreement"), by and among Bleichroeder Acquisition Corp. II ("Bleichroeder"), Bleichroeder Acquisition France Merger Sub 2 ("Merger Sub"), and Pasqal Holding SAS ("Legacy Pasqal"), which provided for, among other things and subject to the terms and conditions contained in the Business Combination Agreement,
- F2. (Continued from footnote 1) (i) the merger of Bleichroeder with and into Merger Sub, with Merger Sub continuing as the surviving company (the "Reincorporation Merger", and Merger Sub as the surviving company of the Reincorporation Merger, the "Bleichroeder Surviving Corporation") and (ii) the merger of Legacy Pasqal with and into the Bleichroeder Surviving Corporation, with the Bleichroeder Surviving Corporation continuing as the surviving company and changing its name to "Pasqal Holding SA" (the "Merger").
- F3. Represents ordinary shares of Legacy Pasqal that were held directly by the Reporting Person, which, upon the consummation of the Issuer's business combination and pursuant to the exchange ratio of 22.7361449900136 set forth in the Business Combination Agreement (the "Exchange Ratio"), were automatically converted into newly issued ordinary shares of the Issuer.
- F4. The exercise price is EUR 50.
- F5. As of the date hereof, 2,000 of the BSPCEs have fully vested and are exercisable for 45,472 ordinary shares of the Issuer. The remaining BSPCEs will vest in three equal annual installments beginning on March 15, 2027.
- F6. Pursuant to the Merger, legacy BSPCEs of Legacy Pasqal were assumed by the Issuer, granting each holder the right to subscribe for ordinary shares of the Issuer, with the number of underlying shares adjusted, as applicable, to reflect the Exchange Ratio.
Key Figures
Key Terms
Business Combination Agreement regulatory
Exchange Ratio financial
Reincorporation Merger regulatory
BSPCEs financial
assumed by the Issuer regulatory
FAQ
What insider transactions did Georges-Olivier Reymond report for PSQL on August 27, 2026?
What are the key terms of the BSPCE warrants reported for PSQL?
Were Reymond’s August 27, 2026 PSQL transactions under a Rule 10b5-1 plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.